Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001113148-19-000013
Filing Date
2019-10-30
Accepted
2019-10-30 15:13:37
Documents
66
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q infi-20190930x10q.htm 10-Q 1168433
2 EXHIBIT 31.1 ex-311q32019.htm EX-31.1 10544
3 EXHIBIT 31.2 ex-312q32019.htm EX-31.2 11791
4 EXHIBIT 32.1 ex-321q32019.htm EX-32.1 6176
5 EXHIBIT 32.2 ex-322q32019.htm EX-32.2 6217
  Complete submission text file 0001113148-19-000013.txt   5068589

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT infi-20190930.xml EX-101.INS 839317
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT infi-20190930.xsd EX-101.SCH 52682
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT infi-20190930_cal.xml EX-101.CAL 81613
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT infi-20190930_def.xml EX-101.DEF 213630
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT infi-20190930_lab.xml EX-101.LAB 584798
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT infi-20190930_pre.xml EX-101.PRE 324950
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

EIN.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31141 | Film No.: 191179659
SIC: 2834 Pharmaceutical Preparations